Table 2 summarizes the main studies assessing potential cancer-related risks. GLP-1 RA is safe and can lower the risk of certain obesity-related cancers. An exception is a recent study indicating an increased BC risk in non-obese diabetic patients treated with GLP-1 RAs [43]. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.